<DOC>
	<DOCNO>NCT01074398</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This research study look biomarkers predict response patient advance ovarian epithelial cancer , fallopian tube cancer , primary peritoneal cancer .</brief_summary>
	<brief_title>Biomarkers Predicting Response Patients With Advanced Ovarian Epithelial Cancer , Fallopian Tube Cancer , Primary Peritoneal Cancer Treated GOG-0172 GOG-0182</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate ERCC1 tumor expression , measure IHC , predictor progression-free overall survival patient advance ovarian epithelial cancer . Secondary - To correlate ERCC1 single-nucleotide polymorphism ( C8092A codon 118 ) ERCC1 tumor expression . OUTLINE : This multicenter study . Blood paraffin-embedded tumor tissue sample analyze ERCC1 tumor expression IHC single-nucleotide polymorphism .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced invasive ovarian epithelial carcinoma , fallopian tube adenocarcinoma , primary peritoneal carcinoma Has undergone optimal surgical staging Has receive chemotherapy either GOG0172 GOG0182 Adequate blood DNA available ERCC1 analysis Adequate tumor paraffinembedded tissue IHC stain PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>peritoneal cavity cancer</keyword>
</DOC>